Strategic partnership R&D Systems by Bio-Techne recently integrated with Refeyn Ltd to pair MauriceFlex icIEF fractionation with Refeyn's mass photometry, enabling correlated charge heterogeneity and molecular weight insights in a streamlined workflow. This presents a compelling cross-sell opportunity for combined instrumentation and software ecosystems.

Topline growth Revenue is in the range of 50 to 100 million with total funding around 98 million, indicating a financially stable organization with resources to invest in advanced analytical platforms, service contracts, and training programs that can drive higher ticket-value deals.

Influence channels Technology stack includes Salesforce, Microsoft 365, LiveChat, and digital advertising tools, suggesting readiness for enterprise sales motions, targeted digital campaigns, and a strong need for CRM-driven customer success and renewals programs.

Product expansion Recent and historical launches in immunoassay kits and high-performance panels, along with integrated instruments based on capillary electrophoresis and microfluidics, indicate openness to new consumables, assay kits, and modular upgrades that complement existing hardware.

Healthcare/defense alignment Past engagements with Berry Aviation for next-generation UAS platforms and emphasis on reliable protein analysis tools imply potential market segments in defense tech, public safety, and government research contracts where validated analytical instruments are critical.